Edward Suarez
Physical Medicine & Rehabilitation · Miami, FLNPI 1285697524
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 354 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,883 and has fallen 84.0% since, to $302 in 2025. Among physical medicine & rehabilitation clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 354 payments — averaging $23.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Amarin Pharma, Inc.$915
- Amgen$747
- Lilly USA, LLC$707
- Novo Nordisk$701
- Boehringer Ingelheim$563
- plus $3K from 24 others
What the payments were for
- Food & beverage$8,209100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 24 | $1,909 |
| Amarin Pharma, Inc. | 40 | $915 |
| Amgen(2 entities) | 34 | $747 |
| Lilly USA, LLC | 46 | $707 |
| Novo Nordisk | 39 | $701 |
| Boehringer Ingelheim | 27 | $563 |
| AstraZeneca | 31 | $529 |
| AbbVie(2 entities) | 22 | $365 |
| Nestle Healthcare Nutrition Inc. | 17 | $302 |
| Exact Sciences | 13 | $280 |
| GSK | 13 | $237 |
| Esperion Therapeutics, Inc. | 6 | $122 |
| Pfizer | 6 | $103 |
| Smith+Nephew | 2 | $88 |
| Idorsia Pharmaceuticals US Inc | 3 | $61 |
| Novartis | 2 | $61 |
| Johnson & Johnson(2 entities) | 3 | $60 |
| Genentech USA, Inc. | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| Kowa Pharmaceuticals America, Inc. | 3 | $54 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $42 |
| Astellas Pharma US Inc | 2 | $41 |
| Merck | 2 | $40 |
| Zyla Life Sciences, Inc. | 2 | $32 |
| Eisai Inc. | 2 | $32 |
| Arbor Pharmaceuticals, Inc. | 2 | $29 |
| Forte Bio-pharma LLC | 1 | $29 |
| Radius Health, Inc. | 1 | $16 |
| Phadia US Inc. | 1 | $16 |
| Corcept Therapeutics | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$1,344
- Vascepa$224
- EVENITY$110
How this compares
$8,209 in reported general payments places this provider in the 95th percentile of 618 physical medicine & rehabilitation providers in Florida.
See all physical medicine & rehabilitation providers in Florida →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 48 | $52,518 |
| JardianceEmpagliflozin | 25 | $38,104 |
| JanuviaSitagliptin Phosphate | 18 | $26,940 |
| MounjaroTirzepatide | 21 | $26,671 |
| EliquisApixaban | 17 | $22,706 |
| RoxicodoneOxycodone Hcl | 12 | $21,658 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $20,496 |
| XareltoRivaroxaban | 12 | $13,016 |
| JanumetSitagliptin Phos/Metformin Hcl | 16 | $9,637 |
| MyrbetriqMirabegron | 11 | $9,486 |
| VascepaIcosapent Ethyl | 15 | $9,335 |
| LinzessLinaclotide | 14 | $9,303 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $7,253 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 150 | $6,629 |
| Tresiba Flextouch U-100Insulin Degludec | 13 | $5,537 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $701 | $52,51848 claims |
| Boehringer IngelheimJardiance | $563 | $38,10425 claims |
| MerckJanuvia, Janumet | $40 | $36,57734 claims |
| Lilly USA, LLCMounjaro | $707 | $26,67121 claims |
| PfizerEliquis | $103 | $22,70617 claims |
| GSKTrelegy Ellipta | $237 | $20,49630 claims |
| Johnson & JohnsonXarelto | $60 | $13,01612 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $529 | $12,77935 claims |
| Astellas Pharma US IncMyrbetriq | $41 | $9,48611 claims |
| AbbVieLinzess | $365 | $9,30314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 618 physical medicine & rehabilitation providers in Florida.
Other physical medicine & rehabilitation in Miami
- Kaivalya DeshpandeMiami$22K
- Amir MahajerMiami$11K
- Lucinda ArenasMiami$9K
- Seyed MostoufiMiami$8K
- Armando AlvarezMiami$6K
- Zainab Al-LawatiMiami$4K
- Anthony GiuffridaFort Lauderdale$271K
- Ryan HafnerSarasota$164K
- Cassandra ListJacksonville$154K
- Marissa McCarthyTampa$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.